WASHINGTON — Rep. Conor Lamb, D-Mt. Lebanon, on Tuesday called for federal officials to investigate the Pennsylvania Department of Health’s response to the COVID-19 outbreak at the Beaver County nursing home where at least 73 residents have died from COVID-19 and 332 have tested positive.
Mr. Lamb drafted the letter to the Centers for Medicare and Medicaid Services after learning state inspectors found the Brighton Rehabilitation and Wellness Center broke state rules by administering hydroxychloroquine to nearly half of its residents in April.
The Pittsburgh Post-Gazette reported last week on the state inspection, during which the nursing home’s medical director stated he knew that he did not have the required state approval to give residents the experimental drug.
The nursing home broke with federal protocols, too, as the U.S. Food and Drug Administration in March had authorized the use of hydroxychloroquine only in hospital settings. In June, the FDA revoked that emergency authorization after deeming it “unlikely to be effective in treating COVID-19” and warned of the possibility of serious side effects.
Mr. Lamb, in the letter, pointed out the state’s inspection report found troubling violations — with little obvious sign of penalties or enforcement by state health officials. The use of hydroxychloroquine directly violated state nursing home regulations that prevent experimental research or treatment without approval from the state and from each resident.
“At this point, the Pennsylvania Department of Health does not appear to have imposed any accountability or punishment on Brighton for the use of hydroxychloroquine without permission,” Mr. Lamb wrote. “For this reason, I request you investigate the state’s response to this unnecessary tragedy at Brighton.”
Read More
A spokesperson for the state health department did not respond Tuesday to a request for comment.
On Wednesday, the spokesman, Nate Wardle, said the department has completed eight inspections at Brighton since April 2020, three of which found the facility was not in compliance with state regulations. Plans of correction were submitted by the operators and accepted by the department, Mr. Wardle said.
“There is an established legal process in place to ensure that all skilled nursing facilities, including Brighton Rehabilitation and Wellness Center, are held accountable,” Mr. Wardle said. The department’s priority is to ensure facilities “fix the issues that are in violation.”
CMS, an arm of the U.S. Department of Health and Human Services, regulates the country’s roughly 15,000 nursing homes but largely defers inspection and enforcement powers to state agencies.
CMS has come under more pressure from lawmakers and patient advocates to respond more forcefully to the COVID-19 outbreak in nursing homes, where elderly or sick residents have been especially vulnerable to the virus.
CMS has estimated, based on incomplete data, that as many as one in four COVID-19 deaths have occurred in nursing homes. A New York Times database pegged that percentage at more than 40% of all COVID-19 deaths. An independent commission, including a UPMC doctor, launched in June to draw up recommendations for CMS to strengthen nursing home oversight.
The letter was Mr. Lamb’s second request for federal intervention at the Brighton facility.
On May 7, Mr. Lamb asked CMS to survey the facility after state inspectors found employees were not properly washing hands and cleaning equipment that was shared among residents who had been infected with the virus and those who had not. Residents were found to have been put in “immediate jeopardy.”
Mr. Lamb on Tuesday thanked CMS for promptly sending federal inspectors in mid-May, which resulted in federal fines of at least $62,580. Health and Human Services Secretary Alex Azar visited Beaver County that month and said federal officials would demand accountability of the facility and state inspectors.
Mr. Azar’s “words suggested that he understood the need for more work to protect the residents at Brighton,” Mr. Lamb wrote Tuesday. “Since then, we have been waiting for actions to match those words, and to assure the families that they will receive both justice and a higher level of healthcare for their loved ones.”
The hydroxychloroquine revelations added yet another wrinkle to the Brighton outbreak.
The antimalarial drug that has been the subject of a political debate after it was aggressively promoted by President Donald Trump as a possible cure or treatment for COVID-19 despite there being little clinical evidence to back that up.
In May, Mr. Trump told reporters he took daily doses of hydroxychloroquine for two weeks, even though he was experiencing no symptoms of the virus.
Rep. Mike Kelly, R-Butler, who contracted the virus in late March, has repeatedly touted the fact that he used the drug, while stopping short of saying he knows that it alleviated the symptoms.
Last week, Mr. Kelly spoke to a virtual audience of The Ripon Society, a conservative group, about the drug: “People ask me now, ‘Do you think that really helped you?’ And this is the one thing I will say: I never had the respiratory problems that some of my friends who were going through it at the same time were going through.”
On June 15, the FDA decided the risks outweighed any benefits and removed its emergency authorization. The FDA questioned the drug’s effectiveness and warning of potentially fatal side effects, such as irregular heart rhythm.
The state’s inspection report of the Brighton facility also noted that short-term use of the drug had been found to have multiple side effects, ranging from a mild upset stomach to heart issues.
Daniel Moore: dmoore@post-gazette.com, Twitter @PGdanielmoore
Story updated at 10:17 a.m. on Aug. 5, 2020, to include comments from the Pennsylvania Department of Health.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.